SCHEMBL23288612

SCHEMBL23288612

N#CB1CCC(C=O)(CO)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297297 0.73 — —
SCHEMBL23288605 0.71 — —
SCHEMBL341929 0.69 — —
SCHEMBL341390 0.68 CYP2C19 (0.30) —
SCHEMBL23288626 0.65 NPSR1 (0.30) —
SCHEMBL20221292 0.64 — —
SCHEMBL19003153 0.64 — —
SCHEMBL21287215 0.64 — —
SCHEMBL24188057 0.63 — —
SCHEMBL24187935 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078120-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2021-04-29 — — WO disclosed
Send feedback